Cargando…
Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes
BACKGROUND: In Fabry nephropathy, podocyturia is an early event that may lead to glomerulosclerosis and chronic kidney disease. The glycocalyx is a potential podocyte damaged compartment in glomerulopathies. We investigated glycocalyx podocalyxin in urinary detached podocytes compared with cytoplasm...
Autores principales: | Trimarchi, Hernán, Canzonieri, Romina, Costales-Collaguazo, Cristian, Politei, Juan, Stern, Anibal, Paulero, Matias, González-Hoyos, Ivan, Schiel, Amalia, Rengel, Tatiana, Forrester, Mariano, Lombi, Fernando, Pomeranz, Vanesa, Iriarte, Romina, Muryan, Alexis, Zotta, Elsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366138/ https://www.ncbi.nlm.nih.gov/pubmed/30747154 http://dx.doi.org/10.1093/ckj/sfy053 |
Ejemplares similares
-
Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease
por: Trimarchi, Hernán, et al.
Publicado: (2017) -
In IgA Nephropathy, Glomerulosclerosis Is Associated with Increased Urinary CD80 Excretion and Urokinase-Type Plasminogen Activator Receptor-Positive Podocyturia
por: Trimarchi, Hernán, et al.
Publicado: (2017) -
Increased urinary CD80 excretion and podocyturia in Fabry disease
por: Trimarchi, H., et al.
Publicado: (2016) -
In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
por: Trimarchi, H., et al.
Publicado: (2017) -
Podocyturia: A Clue for the Rational Use of Amiloride in Alport Renal Disease
por: Trimarchi, H., et al.
Publicado: (2016)